Treatment of Ventricular Tachycardia with Antiarrhythmic Drugs

Introduction to Treatment Strategies

The American College of Cardiology recommends that for hemodynamically stable VT, intravenous amiodarone combined with beta-blockers is the preferred first-line therapy, while lidocaine serves as an alternative, particularly when VT is ischemia-related 1.

The European Society of Cardiology suggests that determining pulse presence and hemodynamic stability is critical, specifically checking for hypotension, chest pain, heart failure, or extreme heart rate, to dictate whether electrical or pharmacological intervention takes priority 2, 3.

The European Heart Journal states that amiodarone is the preferred antiarrhythmic for severe, symptomatic, sustained VT, particularly in patients with heart failure or structural heart disease 4, 1.
The dosing regimen for amiodarone includes a loading dose of 150 mg IV over 10 minutes, followed by a maintenance infusion of 1.0 mg/min for 6 hours, then 0.5 mg/min thereafter 1.
The European Society of Cardiology recommends combining IV amiodarone with beta-blockers for VT storm, as beta-blockers represent the single most effective therapy for polymorphic VT storm 1.

Lidocaine is recommended as an alternative or adjunct to amiodarone, particularly when VT is thought to be ischemia-related, with a dosing regimen that includes an initial bolus of 1.0-1.5 mg/kg IV and a maintenance infusion of 2-4 mg/min 1, 2, 3.

For torsades de pointes, administer magnesium 8 mmol (2 grams) IV, especially if hypomagnesemia is suspected, followed by a maintenance infusion of 2.5 mmol/hour 1, 2.
For VT storm, aggressive beta-blockade is the single most effective therapy, and combining IV amiodarone with beta-blockers is recommended as first-line therapy 1.

Avoid calcium channel blockers (verapamil, diltiazem) in VT patients, especially those with myocardial dysfunction, as they can precipitate VT/VF or profound hypotension 2.
Monitor closely for hypotension, bradycardia, and AV block, and adjust antiarrhythmic therapy accordingly 2, 3.

Always administer IV drugs with a 20 mL saline bolus to aid delivery to central circulation 2, 3.
Correct electrolyte abnormalities (potassium, magnesium) before and during antiarrhythmic therapy 4, 2.